25 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
14 May 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
7:55am
invaluable expertise to Pyxis Oncology's leadership team.
In his role, Stephen will oversee Pyxis Oncology's business development strategies and forge
8-K
EX-10.2
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
of the Investors is an “underwriter.” The Investors shall have the right to have its legal counsel, at such Investor’s expense, review and oversee any
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
, regulatory, including GMP, and project management experience to oversee its third-party manufacturers and to manage manufacturing and quality data
S-4/A
wj7u26ailv8w 5br
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
9ikwoj55fe2 lh
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
DEF 14A
h17 s2w2zi
28 Apr 22
Definitive proxy
4:33pm
10-K
jngvi
29 Mar 22
Annual report
7:36am
10-Q
xuwnjcko30m kcyndah
15 Nov 21
Quarterly report
7:54am
424B4
czwfmi90 g5pljij34
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1/A
EX-10.14
72svig8
30 Sep 21
IPO registration (amended)
9:11pm
S-1
53959z
17 Sep 21
IPO registration
5:00pm